Need to visit a laboratory for a blood test., Visit a Biological Medical Laboratory.
Donna Alvita (Wikimedia Commons) / CC BY-SA 4.0
Diagnosis & Early Detection/July 7, 2026/3 min read

What Claims Data Reveals About DKA at Type 1 Diabetes Diagnosis

A new study examined how well insurance billing records capture cases of diabetic ketoacidosis (DKA) when children are first diagnosed with Type 1 diabetes. Understanding these patterns helps researchers and doctors better track and respond to this serious condition.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningautoantibodiesstaging

Key takeaways

  • About 56% of newly diagnosed children with Type 1 diabetes in the study had DKA at the time of diagnosis.
  • Insurance claims data can identify DKA cases, but the way codes are defined affects how many cases are actually found—stricter definitions miss more cases, while looser definitions catch more but may include non-DKA cases.
  • Children with confirmed DKA at diagnosis had over 5 times more hospital stays than those without DKA.
  • Claims data alone may not tell the complete story of DKA encounters; doctors' lab results provide the most accurate picture.

Understanding DKA at Diagnosis

When children are first diagnosed with Type 1 diabetes, some develop a serious condition called diabetic ketoacidosis (DKA). In DKA, the body breaks down fat too quickly, creating harmful acids that build up in the blood. Researchers want to better understand how often this happens and how it affects healthcare use.

A new study looked at insurance claims data from Colorado to see how well billing records capture DKA cases at the moment of Type 1 diabetes diagnosis. The researchers matched billing information with lab-confirmed diagnoses from a diabetes registry to measure accuracy.

What the Data Showed

The study included 728 children under age 18 who were newly diagnosed with Type 1 diabetes between 2014 and 2019. The average age at diagnosis was about 9.5 years old. Importantly, 56% of these children had laboratory-confirmed DKA at the time they were diagnosed with Type 1 diabetes.

When researchers looked at how insurance codes captured these cases, they found the method matters. Using strict coding rules—looking for both a Type 1 diabetes code AND a DKA code—caught 63% of actual DKA cases but was very accurate (76% specificity). Using looser rules—accepting either code—caught 89% of cases but was less precise, capturing some cases that weren't actually DKA (60% specificity). This trade-off shows that relying on claims data alone may miss real DKA cases or misclassify some records.

Hospital Use and DKA

Children with confirmed DKA at diagnosis had a very different healthcare experience compared to those without DKA. Those with DKA had over 5 times more hospital inpatient stays than children without DKA. In contrast, they had fewer emergency department visits that didn't result in admission—suggesting that when DKA is present, it typically leads to hospitalization rather than outpatient management.

This pattern helps explain why DKA is taken seriously: it requires intensive, inpatient care to safely manage and resolve.

Why This Matters for Research and Care

Insurance claims data is often used to track health conditions and patterns across large populations. However, this study shows that billing codes alone may not capture every DKA case. Laboratory results—blood tests that confirm DKA—remain the gold standard for diagnosis.

For families and doctors: if your child is newly diagnosed with Type 1 diabetes and experiences severe symptoms like rapid breathing, confusion, or fruity-smelling breath, seek emergency care immediately. DKA is a medical emergency. This research helps healthcare systems better recognize and track DKA so that care can be improved over time.

Evidence label

Source: Journal of the Endocrine Society. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.